PubMed中文版

检索结果 7158
原始关键字 阿尔茨海默病 治疗 
转化关键字 ((TITLE_ABS:("Alzheimer disease" Treatment)) OR (KW:("Alzheimer disease" Treatment))) AND SRC:MED 
全部
标题/摘要
作者
按最近排序
按相关度排序
按日期排序
影响因子
出版日期
文献类型
物种
隐藏指标

文献列表

翻译标题
PubMed ID 42640603
发表日期 2026-08-25
作者 Pereira da Silva AM, Santos do Nascimento MDV, Menegucci G, Caruso Novaes Tudella G, Silva Cabeça L, Ribeiro Gonçalves O, Vieira Nogueira B, Oliveira Franco J, Haddad Santos D, Silveira Duarte F, Perry G, de Souza Franco E, Bernadete de Sousa Maia M.
文献标题 Pioglitazone and Cognitive Outcomes in Mild Cognitive Impairment and Alzheimer Disease: A Systematic Review and Meta-Analysis of Randomized Trials.
原始出处 Alzheimer Dis Assoc Disord
影响因子 1.4   期刊引文指标 0.6
PubMed ID 42475614
发表日期 2026-07-20
作者 Jarrell L, Vanhoy S.
文献标题 Doll therapy: Innovative treatment for patients with Alzheimer disease to improve patient and staff safety in a hospital setting.
原始出处 Nursing
影响因子
PubMed ID 42554972
发表日期 2026-08-05
作者 Wang X, Tao Y, Li Q, Yang J, Liu Q, Xu A.
文献标题 The Therapeutic Efficacy of Gold Needle "Regulating Spirit" Acupuncture for Amnestic Mild Cognitive Impairment: Protocol for a Randomized Controlled Trial.
原始出处 JMIR Res Protoc
影响因子 1.5   期刊引文指标 0.47
PubMed ID 42411945
发表日期 2026-07-06
作者 Nakamura Y, Tsushio T, Tanahashi M, Suganami H, Omori T, Nishiyama K, Aoki H, Nagakura N.
文献标题 Post Hoc Subgroup Analysis by Disease Severity in a Non-Inferiority Trial of Donepezil 27.5 mg Transdermal Formulation in Japanese Patients With Mild-to-Moderate Alzheimer Disease.
原始出处 Alzheimer Dis Assoc Disord
影响因子 1.4   期刊引文指标 0.6
PubMed ID 42497640
发表日期 2026-06-26
作者 Malcangio M, Sideris-Lampretsas G.
文献标题 Chronic pain in Alzheimer disease and the role of neuroimmune interactions.
原始出处 Pharmacol Rev
影响因子 17.3   期刊引文指标 2.8
PubMed ID 42128444
发表日期 2026-05-13
作者 Atri A, Apostolova LG, Iwata A, Wessels AM, Atkins A, Lu M, Ye W, Ryan S, Doty EG.
文献标题 Clinical Meaningfulness of Donanemab in Early Symptomatic Alzheimer Disease: Data From the Randomized Phase 3 TRAILBLAZER-ALZ 2 Trial.
原始出处 Neurol Clin Pract
影响因子 3.2   期刊引文指标 0.81
PubMed ID 42485476
发表日期 2026-06-01
作者
文献标题 Nabilone for Behavioural and Psychological Symptoms of Dementia: Drugs
原始出处
影响因子
PubMed ID 41926104
发表日期 2026-05-01
作者 Devanand DP, Wei R, Qian M.
文献标题 Treatment of Early Symptomatic Alzheimer Disease With Valacyclovir-Reply.
原始出处 JAMA
影响因子 55   期刊引文指标 11.47
PubMed ID 41926105
发表日期 2026-05-01
作者 Kosaka M, Kami M.
文献标题 Treatment of Early Symptomatic Alzheimer Disease With Valacyclovir.
原始出处 JAMA
影响因子 55   期刊引文指标 11.47
PubMed ID 42015793
发表日期 2026-04-01
作者 Gao L, Watson R, Yassi N.
文献标题 Cost-Effectiveness of Donanemab for Early Alzheimer Disease in Australia.
原始出处 Med J Aust
影响因子 8.5   期刊引文指标 1.56
PubMed ID 41881052
发表日期 2026-03-25
作者 Noguchi-Shinohara M, Ono K.
文献标题 Successful Amyloid Removal by Donanemab Treatment in a Female Patient With Alzheimer Disease: A Case Report.
原始出处 Neurology
影响因子 8.5   期刊引文指标 2.54
PubMed ID 41405876
发表日期 2026-02-10
作者
文献标题 Valacyclovir Treatment of Early Symptomatic Alzheimer Disease: Research Summary.
原始出处 JAMA
影响因子 55   期刊引文指标 11.47
PubMed ID 41405855
发表日期 2026-02-01
作者 Devanand DP, Wisniewski T, Razlighi Q, Qian M, Wei R, Andrews HF, Acosta EP, Bell KL, Pelton GH, Deliyannides D, Perrin AC, Caccappolo E, Gershon AA, Prasad KM, Kreisl WC, Mintz A, Huey ED.
文献标题 Valacyclovir Treatment of Early Symptomatic Alzheimer Disease: The VALAD Randomized Clinical Trial.
原始出处 JAMA
影响因子 55   期刊引文指标 11.47
PubMed ID 41082199
发表日期 2025-12-01
作者 Lu M, Kim MJ, Collins EC, Shcherbinin S, Ellinwood AK, Yokoi Y, Brooks DA, Hansson O, Knopman DS, Sims JR, Mintun MA.
文献标题 Posttreatment Amyloid Levels and Clinical Outcomes Following Donanemab for Early Symptomatic Alzheimer Disease: A Secondary Analysis of the TRAILBLAZER-ALZ 2 Randomized Clinical Trial.
原始出处 JAMA Neurol
影响因子 21.3   期刊引文指标 6.16
PubMed ID 41359335
发表日期 2025-12-01
作者 Cantoni V, Casula EP, Tarantino B, Cupidi C, Huber N, Altomare D, Premi E, Zummo E, Esposito R, Leonardi C, Herukka SK, Solje E, Ferrari A, Cotelli MS, Gasparotti R, Martorana A, Fracassi C, Santarnecchi E, Koch G, Haapasalo A, Grassi M, Benussi A, Borroni B.
文献标题 Home-Based Gamma Transcranial Alternating Current Stimulation in Patients With Alzheimer Disease: A Randomized Clinical Trial.
原始出处 JAMA Netw Open
影响因子 9.7   期刊引文指标 2.95
PubMed ID 41176545
发表日期 2025-11-02
作者 El Hajj W, Pujo-Menjouet L, Tine LM, Volpert V.
文献标题 Modelling of anti-inflammatory treatment in the Alzheimer disease: optimal regimen and outcome.
原始出处 Bull Math Biol
影响因子 2.2   期刊引文指标 0.65
PubMed ID 40955711
发表日期 2025-09-16
作者 Tan A, Wang Z, Aumont E, Li A, Qin X, Yang X, Feng W, Yang J, Li X, Xiao J, Zhou B, Xing Y, Yi Y, Li J.
文献标题 Determinants of Treatment Willingness and Willingness-to-Pay for Lecanemab in China: A Network Analysis.
原始出处 Alzheimer Dis Assoc Disord
影响因子 1.4   期刊引文指标 0.6
PubMed ID 39805666
发表日期 2025-07-01
作者 Ricaurte-Fajardo A, Ivanidze J, Zhang D, Mahmud M, Yasen W, Ravdin L, Pahlajani S, Leon M, Nordvig AS, Chiang GC.
文献标题 Antiamyloid Therapy and Cerebral Blood Flow Changes on MRI: A Potential Longitudinal Biomarker of Treatment Response?
原始出处 AJNR Am J Neuroradiol
影响因子 3.7   期刊引文指标 1.02
PubMed ID 40222353
发表日期 2025-04-14
作者 Felbecker A, Felbecker A, Rouaud O, Rouaud O, Lathuiliere A, Allali G, Sollberger M, Meyer-Heim T, Monsch AU, Lövblad KO, Becker S, Barro-Belaygues N, Popp J, Bürge M, Lindheimer K, Gietl A, Jung HH, Georgescu D, Meyer R, Frisoni GB.
文献标题 Anti-Amyloid Monoclonal Antibodies for the Treatment of Alzheimer Disease: Intersocietal Recommendations for Their Appropriate Use in Switzerland.
原始出处 Neurodegener Dis
影响因子 2.6   期刊引文指标 0.62
PubMed ID 37930677
发表日期 2023-12-01
作者 Ballard C.
文献标题 Brexpiprazole for the Treatment of Agitation and Aggression in Alzheimer Disease.
原始出处 JAMA Neurol
影响因子 21.3   期刊引文指标 6.16